Clobetace 0.05% Ointment
By Clobetace
Rx
10gm Ointment in a Tube

Composition
Clobetasol(0.05% w/w)

Manufacturer - Wallace Pharmaceuticals Pvt Ltd
Wallace Pharmaceuticals Pvt. Ltd., 3rd Floor, Dempo Trade Centre Bldg., Patto Plaza, EDC Complex, Panaji 403001, Goa, India.

Expires on or after
September, 2025

liver
Safety Advice for the use of Clobetace 0.05% Ointment in relation to the Liver When it comes to liver safety, there is currently no known established interaction associated with the use of Clobetace 0.05% Ointment. This means that there are no specific cautions or warnings related to the liver when using this ointment. However, it's always important to be cautious when using any new product, especially if you have pre-existing liver conditions or concerns. In such cases, it is advisable to consult with your healthcare provider before using Clobetace 0.05% Ointment to ensure it is safe for your liver health. Always follow the recommended usage instructions and if you experience any unusual symptoms or side effects while using the ointment, seek medical advice promptly.

kidney
No interaction or issues related to kidney function have been found or established with Clobetace 0.05% Ointment. If you have concerns about using this product due to kidney issues, it is advised to consult with your doctor for proper guidance before using Clobetace 0.05% Ointment.

alcohol
No interaction has been found between alcohol and Clobetace 0.05% Ointment. It is important to consult your doctor regarding the use of alcohol during pregnancy.

driving
It is better to consult your doctor. Refrain from driving if you have symptoms impairing focus and reaction time when using Clobetace 0.05% Ointment.

pregnancy
Clobetace 0.05% Ointment may not be safe to use during pregnancy. Animal studies have shown potential harm to the developing baby. Consult your doctor for a careful assessment of benefits and risks before using this product.

breastfeeding
Caution is advised when using Clobetace 0.05% Ointment during breastfeeding as limited human data suggests potential harm to the baby through breastmilk transmission.
Habit Forming | No |
Chemical Class | Gluco/mineralocorticoids, progestogins and derivatives |
Therapeutic Class | DERMA |
Action Class | - |
₹31.5
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024